SEC Form 4 · accession 0001209191-15-061181
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard S Levy
Officer — EVP, Chief Drug Dev Officer
Period of report
Jul 15, 2015
Accepted (ET)
Jul 16, 2015 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2015 | M | 70,217 | $17.79 | A | 91,444 | D | |
| Common StockF1 | Jul 15, 2015 | S | 70,217 | $120.00 | D | 21,227 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $17.79 | Jul 15, 2015 | M | 70,217 | D | — | Jan 18, 2019 | Common Stock | 70,217 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F2Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.